A Pennsylvania Supreme Court justice, voicing harsh criticisms for the Commonwealth Court and suggesting the state’s hiring of outside counsel on a contingency fee basis lengthened the 10-year litigation, has led a split high court in its decision to remand for reconsideration $80 million in damages assessed against two pharmaceutical companies.
In a strongly worded opinion announcing the judgment of the court, Justice Thomas G. Saylor said the state’s claims against Bristol-Myers Squibb and Johnson & Johnson for allegations the state overpaid for prescription drugs for seniors completely ignored the fact that the drug companies have given more than a billion dollars in rebates to the state over the years.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]